These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2568416)

  • 21. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
    Yoshida N; Omoya H; Ito T
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo.
    Eglen RM; Lee CH; Smith WL; Johnson LG; Whiting RL; Hegde SS
    J Pharmacol Exp Ther; 1993 Aug; 266(2):535-43. PubMed ID: 8355189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiemetic effects of YM060, a potent and selective serotonin (5HT)3-receptor antagonist, in ferrets and dogs.
    Kamato T; Miyata K; Ito H; Yuki H; Yamano M; Honda K
    Jpn J Pharmacol; 1991 Nov; 57(3):387-95. PubMed ID: 1813664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model.
    Barnes NM; Cheng CH; Costall B; Ge J; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1992 Jul; 218(1):91-100. PubMed ID: 1356807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LY277359 maleate: a potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1990 Jul; 254(1):350-5. PubMed ID: 2366187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diphenidol has no actual broad antiemetic activity in dogs and ferrets.
    Nakayama H; Yamakuni H; Nakayama A; Maeda Y; Imazumi K; Matsuo M; Mutoh S
    J Pharmacol Sci; 2004 Nov; 96(3):301-6. PubMed ID: 15528840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zacopride: anxiolytic profile in rodent and primate models of anxiety.
    Costall B; Domeney AM; Gerrard PA; Kelly ME; Naylor RJ
    J Pharm Pharmacol; 1988 Apr; 40(4):302-5. PubMed ID: 2900320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonism of serotonin3 (5-HT3) receptors within the blood-brain barrier prevents cisplatin-induced emesis in dogs.
    Gidda JS; Evans DC; Cohen ML; Wong DT; Robertson DW; Parli CJ
    J Pharmacol Exp Ther; 1995 May; 273(2):695-701. PubMed ID: 7752072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
    Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-ranging trial of zacopride: the emetic antiemetic?
    Pisters KM; Kris MG; Tyson LB; Clark RA; Gralla RJ
    J Natl Cancer Inst; 1992 May; 84(9):717-8. PubMed ID: 1569606
    [No Abstract]   [Full Text] [Related]  

  • 31. The actions of fentanyl to inhibit drug-induced emesis.
    Barnes NM; Bunce KT; Naylor RJ; Rudd JA
    Neuropharmacology; 1991 Oct; 30(10):1073-83. PubMed ID: 1661861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
    Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine.
    Foss JF; Yuan CS; Roizen MF; Goldberg LI
    Cancer Chemother Pharmacol; 1998; 42(4):287-91. PubMed ID: 9744773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiolytic-like activity of R(+)- and S(-)-zacopride in mice.
    Young R; Johnson DN
    Eur J Pharmacol; 1991 Aug; 201(2-3):151-5. PubMed ID: 1686755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zacopride and BRL 24924 induce an increase in EEG-energy in rats.
    Boddeke HW; Kalkman HO
    Br J Pharmacol; 1990 Oct; 101(2):281-4. PubMed ID: 2257436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret.
    Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Rudd JA
    Neuropharmacology; 2010 Feb; 58(2):383-91. PubMed ID: 19825380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.
    Waeber C; Pinkus LM; Palacios JM
    Eur J Pharmacol; 1990 Jun; 181(3):283-7. PubMed ID: 2384135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective blockade of cytotoxic drug-induced emesis by 5-HT3 receptor antagonists in Suncus murinus.
    Torii Y; Saito H; Matsuki N
    Jpn J Pharmacol; 1991 Jan; 55(1):107-13. PubMed ID: 2041220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of 5-hydroxytryptamine3 receptors prevents cisplatin-induced but not motion- or xylazine-induced emesis in the cat.
    Lucot JB
    Pharmacol Biochem Behav; 1989 Jan; 32(1):207-10. PubMed ID: 2734331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of three preclinical models for nausea and vomiting assessment.
    Goineau S; Castagné V
    J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.